Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT06625138Not ApplicableRecruiting

Trial of Latex Vs Non-latex Hemorrhoid Banding

Role: lead

NCT05131594Enrolling By Invitation

Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)

Role: lead

NCT04922944Completed

Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients

Role: lead

NCT02528539Not ApplicableCompleted

Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP)

Role: lead

NCT02456649Not ApplicableCompleted

Study of the Outcomes of Intraoperative Margin Assessment With MarginProbe

Role: lead

NCT02913573Phase 2Unknown

Effect of Pectoral Nerve Block on Post-op Pain in Patients Undergoing Mastectomy and Immediate Reconstruction

Role: lead

All 7 trials loaded